RULE BILLS
**A rule bill is a bill passed through a full House vote under a rule that has been voted and agreed upon by the Rules Committee. Rule bills require a simple majority of the House to pass (218 votes) through a recorded vote.

Result and Date	Bill #	Bill Title	My Vote	What it means for you and your family
5/9/19 PASSED 230-183-1	H.R.986	Protecting Americans With Preexisting Conditions Act of 2019	NO	This legislation’s title has nothing to do with its substance. H.R. 986 nullifies “State Relief and Empowerment Waivers” which are used to innovate and provide experimental options to decrease costs and increase coverage,  so long as it meets certain criteria. This legislation has nothing to do with protecting pre-existing conditions and instead stifles innovation in insurance.

 

SUSPENSION BILLS

**A suspension bill is a bill passed by the House through suspending the rules to move quickly, circumventing the House Rules Committee. Suspension bills are typically less controversial pieces of legislation, and as the rules are being suspended, they require a higher threshold, two-thirds of those voting in the House, to pass. Additionally, these bills are often passed by a voice vote, without a formal roll call vote.

Result and Date	Bill #	Bill Title	My Vote	What it means for you and your family
5/7/19 PASSED	H.R. 2002	Taiwan Assurance Act of 2019	YES	Passed by voice.
5/7/19 PASSED 414-0	H.Res 273	Reaffirming the United States commitment to Taiwan and to the implementation of the Taiwan Relations Act	YES	This legislation reaffirms the United States commitment to Taiwan and to the implementation of the 1979 Taiwan Relations Act.
5/7/19 PASSED 400-16	H.R. 1704	Championing American Business Through Diplomacy Act of 2019	YES	This legislation establishes the position of Assistant Secretary of State for Economic and Business Matters within the State Department. Additionally, the legislation establishes that the principal duty of a diplomatic mission to a foreign country is the promotion of U.S. economic and commercial interests in that country.
5/8/19 PASSED 421-0	H.R. 1520	Purple Book Continuity Act	YES	H.R. 1520 codifies the requirement to list: name of biologic; date of licensing; studies necessary for biosimilar applications; updates every 30 days; patents disclosed during “patent dance”; and withdrawal or suspension of licensure. The bill also requires FDA to report recommendations of what patents should be listed in the Purple Book going forward.
5/8/19 PASSED 422-0	H.R. 1503	Orange Book Transparency Act of 2019	YES	Codifies the current requirement to list drug substance patents, drug product patents, and method-of-use patents; allows the listing of other patents at agency discretion; and prohibits the listing of drug-delivery device patents. It further requires maintenance to notify FDA of any court decision finding a patent invalid and requires that FDA remove those patents from the Orange Book.
5/8/19 PASSED	H.R. 1328	ACCESS BROADBAND Act	YES	Passed by voice.

2019 PAST VOTES:

My Votes – Week of April 29

how i voted – week of april 8

HOW I VOTED – WEEK OF APRIL 1

HOW I VOTED – WEEK OF MARCH 25

HOW I VOTED – WEEK OF MARCH 11